New methods for assessing heart function in health and disease
Official title: Development of Novel Physiological CMR Methods in Health and Disease
Run by Sheffield Teaching Hospitals NHS Foundation Trust · NCT03854071 · Data updated 2026-11-12
This study is testing new heart imaging techniques to see how well they can measure heart function in both healthy people and those with heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 80 Years |
| Sex | All |
| Enrollment | 135 (estimated) |
| Sponsor | Sheffield Teaching Hospitals NHS Foundation Trust Academic / other |
| Locations | 1 site (Sheffield, England) |
| Status | Recruiting |
| Started | July 30, 2018 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2031 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT03854071 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy volunteers and patients aged 20 to 80 with suspected or known heart disease.
✕Probably not a fit
Patients with severe heart failure requiring IV therapy or significant valvular heart disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop and evaluate novel cardiovascular magnetic resonance (CMR) methods to assess heart function in both healthy individuals and patients with suspected or known heart disease. Participants will undergo physiological stress tests using advanced CMR imaging techniques, including four-dimensional flow CMR, to better understand cardiac function and flow dynamics. The study will involve five clinical subgroups, focusing on conditions such as heart failure and coronary artery disease, and will assess the impact of preload on cardiac performance. Follow-up scans will be conducted to evaluate the therapeutic implications of these new metrics.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for heart disease, enabling more effective treatment strategies.
How similar studies have gone: Other studies have shown promise in using advanced imaging techniques for cardiac assessment, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy Volunteers age 20 to 80, recruited from Sheffield Teaching Hospitals staff members * Patients age 20 to 80 with suspected or known heart disease (group 1 to 5) * Capable of giving written informed consent Exclusion Criteria: * Inability to perform the study protocol secondary to severe heart failure requiring IV therapy * Patients recruited in the suspected CAD and acute myocardial infarction arms of the study and in need for detection of ischaemia should not have any past medical history of MI, ACS or cardiomyopathy * Patients with significant valvular heart disease will be excluded from any patient group * Patient with in atrial fibrillation will be excluded * Contraindication to MRI (as per standard MRI screening questionnaire issued to patients prior to clinical MRI procedures)
Where it's running
-
Sheffield Teaching Hospitals NHS FT
Sheffield, England, United Kingdom Recruiting
Study contacts
- Study coordinator: Helen Denney
- Email: H.Denney@nhs.net
- Phone: 0114 2269047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
-
Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries
This trial tests whether bypass surgery (CABG) or stents (PCI) lead to better survival, fewer major heart problems, and improved quality of life for adults with reduced left ventricular function (LVEF ≤40%) and multivessel coronary disease.
-
Digital enhancements to Phase III cardiac rehabilitation for ASCVD patients
This trial tests whether adding the DEEPER digital program to standard Phase III cardiac rehab helps people with ASCVD see a better 6-month improvement in a health and mood composite score.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.